Gemini Explorations CLOSES on Financing for the Re-Development of the Los Chorros Gold Mine

Stocks to Watch: Gemini Explorations, Inc.  (OTCBB: GXPI), AskMeNow Inc.  (OTCBB: AKMN), INNOVIVE Pharmaceuticals  (OTC BB:IVPH) , Vyteris Inc. (OTC BB:VYHN), SinoFresh HealthCare, Inc. (OTC BB:SFSH)

Featured Stock: Gemini Explorations, Inc.

(OTCBB: GXPI)

Current Price (0.14)

http://www.smallcapstockanalyst.com/

Gemini Explorations Closes on Financing for the Re-Development of the Los Chorros Gold Mine

Mine Modernization Projected to Yield US$12,900,000 of Net Cash Flow to Gemini

CALGARY, AB----Dec 10, 2007 -- Gemini Explorations Inc. ("Gemini") (OTC BB:GXPI.OB - News) is pleased to report that it has completed negotiations for financing the modernization and complete re-development of the Los Chorros Gold Mine. The first tranche of US$500,000 should be received by Gemini in the next 5 days and the second tranche of US$300,000 within 14 days. The total cost of the project is estimated to be US$595,900, adding a contingency factor of 30% would bring the maximum projected total to US$774,700.

The Los Chorros Mine is currently being mined with extremely antiquated equipment and this report further solidifies Gemini's belief that the project could be turned into a highly efficient producing gold project with low capital costs. Current mining operations at Los Chorros recover a low percentage of the available gold and precious metals present on the property. The plant would initially run at 30 to 50 tonnes/day with a targeted production rate of 100 tonnes per day during the first year. Minera Primecap Geological Services (MPGS) reported that a 100 tonne per day production rate would produce US$1,080,280 monthly and over US$12,900,000 annually. These estimates are based on US$730 per ounce gold with US$200 per ounce operating and production costs netting US$530 per ounce.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the expectation that the financing will close on specified dates, the expectation of the gold production of the property, the expected completion date of the redevelopment and modernization of the Los Chorros Gold mine and the low capital costs to upgrade the Los Chorros operating plant and the net cash flow estimates.Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the 2006 fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:

     Michael Hill

     President

     Gemini Explorations, Inc

     Suite 103, 240-11th Ave SW

     Calgary, AB T2R 0C3

     http://www.geminiexploration.com  email: info@geminiexploration.com

     403-697-4877

Source: Gemini Explorations, Inc.

For an in-depth analyst report, please visit: www.SmallCapStockAnalyst.com

AskMeNow Inc.

(OTCBB: AKMN)

Current Price (0.17)

http://www.smallcapstockanalyst.com/

IRVINE, CA----Dec 10, 2007 -- AskMeNow Inc. (OTC BB:AKMN.OB - News), a leader in intelligent mobile search technology, announced today that it will host a conference call for investors at 4:00 PM ET (1:00 PM PT) on December 18th, 2007 to discuss business achievements and future opportunities.                  AskMeNow is the easiest, most convenient way to access information on the Internet or from local content from your cell phone or mobile PDA device. The first mobile lifestyle network, AskMeNow utilizes its proprietary technology to offer a natural language based interaction and dynamic content provision platform designed for simple and quick information retrieval. The Company generates revenues through per usage fees and one to one contextual mobile advertising sponsorships. AskMeNow launched officially in November 2005. The Company is based in Irvine, California. Please visit www.askmenow.com for more information.

INNOVIVE Pharmaceuticals

(OTC BB:IVPH)

Current Price (1.37)

http://www.smallcapstockanalyst.com/

ATLANTA--Dec 10--INNOVIVE Pharmaceuticals, Inc. (OTCBB: IVPH - News) today presented clinical data from the first part of a two-part Phase I study of its drug candidate INNO-406, a potent, oral, dual Bcr-Abl and Lyn-kinase inhibitor in patients with Chronic Myelogenous Leukemia (CML). In the study, INNO-406 was shown to be well tolerated and demonstrated activity in patients with CML who are intolerant or resistant to imatinib (Gleevec®) and multiple second generation tyrosine kinase inhibitors. The data were presented today at an oral presentation at the 49th American Society of Hematology Annual Meeting in Atlanta.                 INNOVIVE Pharmaceuticals, Inc. acquires, develops and commercializes novel therapeutics addressing significant unmet medical needs in the fields of oncology and hematology. The company has four drug programs in clinical development: INNO-406, Tamibarotene, INNO-206, and INNO-305, for the treatment of chronic myelogenous leukemia, acute promyelocytic leukemia, small cell lung cancer, and acute myelogenous leukemia, respectively. For additional information visit  www.innovivepharma.com.

Vyteris Inc.

(OTC BB:VYHN)

Current Price (0.54)

http://www.smallcapstockanalyst.com/

FAIR LAWN, N.J.--Dec 10--Vyteris, Inc. (OTCBB: VYHN - News), manufacturer of LidoSite®, the first active transdermal patch approved by the U.S. Food and Drug Administration for the pain associated with blood draws (venipuncture), IV (intravenous) cannulations and laser ablation of superficial skin lesions, today announced the appointment Rafael Espinal as its new vice president of manufacturing, in a move to significantly deepen its management team for manufacturing and production.               Vyteris, Inc., a wholly owned subsidiary of Vyteris Holdings (Nevada), Inc. (OTCBB: VYHN - News), is the maker of the first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration (FDA). Vyteris' proprietary active transdermal drug delivery (iontophoresis) technology delivers drugs comfortably through the skin using low-level electrical energy. This active patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that can result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. Vyteris' first product, LidoSite®, which provides dermal analgesia prior to venipuncture (IV catheter insertions, blood draws, etc.) and superficial dermatological procedures, was the first FDA approved active patch. For more information, please visit our website at www.vyteris.com.

SinoFresh HealthCare, Inc.

(OTC BB:SFSH)

Current Price (0.19)

http://www.smallcapstockanalyst.com/

ENGLEWOOD, FL----Dec 10, 2007 -- Charles Fust, Chief Executive Office of SinoFresh HealthCare, Inc. (OTC BB:SFSH.OB - News), will be featured in an exclusive interview with the Tampa Tribune scheduled for Dec. 14th for a special edition regarding MRSA "Super Bug."This is the first time SinoFresh Healthcare will be linked with the disease. To read more about MRSA pick up a copy or visit the paper online at http://www.tampatrib.com/                  SinoFresh HealthCare, Inc. (OTC BB:SFSH.OB - News) is a developer and marketer of innovative upper respiratory system therapies. The company is researching broad-spectrum antiseptic approaches to reducing viral, bacterial and fungal organisms that are suspected to cause pathogenesis of the mouth, nose and throat. The company's lead product, SinoFresh(TM) Nasal and Sinus Care, is a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants. The company is also researching how antiseptic cleansing may alleviate chronic sinus distress, a condition that may affect 37 million Americans annually. SinoFresh(TM) products are available in Rite Aid, CVS, Duane Reade and other drug, grocery and mass merchandise retailers. More information is available at www.sinofresh.com.

Penny Stock research reports are provided by SmallCapStockAnalyst.com, where visitors can sign up for our penny stock and Small Cap Stock newsletter. The newsletter will update investors with Growth Stocks when we begin coverage on new small cap companies. Penny Stocks trade in the Small Cap Stock Market, being informed is a critical component to making decisions. Penny Stock coverage from SmallCapStockAnalyst.com strives to keep you, the Investor, updated on companies looking to move ahead of the pack. Sign up today to receive growth stock tips and smallcap newsletter to stay informed of your investments. Allow SmallCapStockAnalyst.com to provide you with the latest research reports on pennystocks and Growth Stock Picks for your Stock Investing needs. SmallCapStockAnalyst.com specializes in providing investor relations and disseminating information to the small cap stock investor.

SmallCapStockAnalyst.com is owned and operated by Iron Consulting.

Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), SmallCapStockAnalyst.com is owned and operated by Iron Consulting. Iron Consulting has received seventy one thousand dollars from Equity Alliance Intl. LLC www.equityallianceir.com for a two month internet marketing program. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Market Advisors Inc.

The information and opinions in this report were prepared by Market Advisors Inc. (located in Nebraska) who does receive fees for services including preparation of this report. For this report, officers of Market Advisors Inc received $2,500 from a non-affiliated third party. This is not an offer to buy or sell securities nor should this report be construed as investment advice. Information or statements are subject to numerous risks and uncertainties that cause such statements not to prove accurate. Market Advisors, Inc. does not disseminate, nor is it liable for the dissemination by any third party of this information.